Industry

Established sites join Iterative Health’s elite site network, expanding the company’s cardiovascular research capabilities CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Health, a healthcare technology and services company powering the acceleration of clinical research, today announced the acquisition of three cardiology sites from NextStage Clinical Research with Bourne Partners serving as exclusive financial advisor on the transaction. Located across … [Read more…]

MISSISSAUGA, Ontario–(BUSINESS WIRE)–Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2026 results on Thursday, May 21, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, May 21, 2026, at 8:30am ET. To view, … [Read more…]

TORONTO–(BUSINESS WIRE)–OBIO® and Intellectual Property Ontario (IPON) have renewed their memorandum of understanding (MOU) to ensure that Ontario’s next generation of companies developing innovative human health products continue to access optimal intellectual property (IP) protection and commercialization support. Through this agreement, OBIO® and IPON will continue to jointly assist Ontario’s early-stage life sciences and health … [Read more…]

LONDON & NEW YORK–(BUSINESS WIRE)–$CMPS #Biotech–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the RBC Capital Markets Global Healthcare Conference on May 19-20, 2026 and will participate in a fireside chat on May 19 at 10:00am ET. A … [Read more…]

Arcadea expands its position in Brazilian healthcare software with its fourth investment in the sector TORONTO & RIO DE JANEIRO–(BUSINESS WIRE)–Arcadea Group, a preeminent, long-term investor in global software businesses, today announced the acquisition of Sofis, a leading providing of mission-critical software to the Brazilian healthcare sector, focused on hemotherapy and cell therapy. Founded in … [Read more…]

Approval is based on data from the ASCERTAIN-V clinical trial demonstrating that INQOVI in combination with venetoclax met complete response endpoints, with no new safety concerns reported INQOVI is also approved in the U.S. as a treatment for myelodysplastic syndromes and chronic myelomonocytic leukemia PRINCETON, N.J. & TOKYO–(BUSINESS WIRE)–Taiho Oncology, Inc. and Taiho Pharmaceutical Co., … [Read more…]

SCORPIO-PEP is the first and only Phase 3 study of an oral antiviral to meet the primary endpoint of preventing symptomatic COVID-19 following exposure to an infected individual* Ensitrelvir is an investigational oral antiviral that could offer a new approach to preventing COVID-19 by blocking viral replication during the critical window between exposure and COVID-19 … [Read more…]

Industry leaders from across the health ecosystem, including Clue, Ema EQ, Oura, and Willow, will set the first clinically rigorous, transparent standards for AI in women’s health SAN FRANCISCO–(BUSINESS WIRE)–Today marks a major step forward in women’s health as Willow Innovations, Inc. (Willow), the maternal health pioneer that revolutionized the breast-pumping experience, and Ema EQ, … [Read more…]

New organization leverages manufacturing, PBMC isolation, and cryopreservation services across multiple facilities, supporting cell therapy programs from preclinical through commercial supply Core Excellos team retained; existing customer programs to continue without interruption MIAMI–(BUSINESS WIRE)–OrganaBio, LLC (“OrganaBio”), a manufacturer of GMP cells and blood products and provider of cell isolation and cryopreservation services, has acquired substantially … [Read more…]

Medtech leader with deep orthopedic extremities experience enhances board depth as shoulder-focused company advances growth and strategic objectives NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (“Catalyst”), a private medical device technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced the appointment of Gordon Van Ummersen to its board of directors. “I am pleased to join … [Read more…]